Botanical species · safety record

Eriophyllum lanatum

The EFSA Compendium of Botanicals holds 4 constituent measurements for Eriophyllum lanatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eriophyllum lanatum (Pursh) J.Forbes

4Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Sesquiterpene lactones3
  • Furan derivatives1

Plant parts

  • Unspecified2
  • Aerial part of plants1
  • Roots and other underground parts1

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Furan derivativesRoots and other underground partsSolvent extraction6.8 Microgram/gramNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene lactonesUnspecifiedSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Sesquiterpene lactonesUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene lactonesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kupchan, S.M., Baxter, R.L., Chiang, C.-K., Gilmore, C.J., Bryan, R.F. Eriolangin and eriolanin, novel antileukaemic seco-eudesmanolides from Eriophyllum lanatum. Journal of the chemical society, chemical communications, 1973, no. 21, p. 842-843. DOI
  2. Bohlmann, Ferdinand., Zdero, Christa., Jakupovic, Jasmin., Robinson, Harold., King, Robert M. Naturally occurring terpene derivatives. Part 350. Eriolanolides, eudesmanolides, and a rearranged sesquiterpene from Eriophyllum species. Phytochemistry (elsevier), 1981, p. 2239-2244.
  3. Blees, Johanna S., Bokesch, Heidi R., Rubsamen, Daniela., Schulz, Kathrin., Milke, Larissa., Bajer, Magdalena M., Gustafson, Kirk R., Henrich, Curtis J., McMahon, James B., Colburn, Nancy H., Schmid, Tobias., Brune, Bernhard. Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase beta-TrCP1. . Plos one, 2012, vol. 7, no. 10, p. e46567. DOI
  4. Page, JE., Huffman, MA., Smith, V., Towers, GHN. Chemical basis for Aspilia leaf-swallowing by chimpanzees: A reanalysis. Journal of chemical ecology, 1997, vol. 23, no. 9, p. 2211-2226. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue